Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,206
Closed -$220K – 248
2026
Q2
$220K Buy
+4,206
New +$222K 0.1% 212

Other funds holding GSK

XXI Wealth's GSK Position: Q3 2026 in Review

XXI Wealth sold out of GSK (GSK) in Q3 2026, closing a stake of 4,206 shares — an estimated $220K sold.

XXI Wealth first reported a position in GSK in Q2 2026 and held it in 1 quarter. The position peaked at $220K in Q2 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • XXI Wealth reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • XXI Wealth sold 4,206 GSK shares in Q3 2026, an estimated $220K.
  • XXI Wealth first reported a position in GSK in Q2 2026 and held it in 1 quarter.
  • XXI Wealth's GSK position peaked at $220K in Q2 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.